Guardant Health
GH
#981
Rank
C$34.33 B
Marketcap
C$255.88
Share price
2.54%
Change (1 day)
158.13%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): C-$4.86

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is C-$4.89. In 2025 the company made an earnings per share (EPS) of C-$4.64 an increase over its 2024 EPS that were of C-$4.99.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$4.864.77%
2025C-$4.64-7.02%
2024C-$4.99-16.82%
2023C-$6.00-33.13%
2022C-$8.9760%
2021C-$5.6155.04%
2020C-$3.62207.14%
2019C-$1.18-19.81%
2018C-$1.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
C-$0.05042-98.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
C-$3.43-29.80%๐Ÿ‡บ๐Ÿ‡ธ USA